Results 41 to 50 of about 158,277 (182)

Comparative analysis of Plasmodium falciparum dihydrofolate-reductase gene sequences from different regions of India

open access: yesHeliyon, 2020
Molecular surveillance of the drug resistance genes in parasite can be used for monitoring/surveillance of drug resistance in endemic malaria areas. Here we report the prevalence of single nucleotide polymorphisms (SNPs) in dihydrofolate reductase (dhfr)
Amit Kumar, S.K. Gahlawat, Vineeta Singh
doaj   +1 more source

Trimethoprim resistant dihydrofolate reductases in normal faecal flora isolated in India [PDF]

open access: yes, 1994
A high incidence of resistance to trimethoprim has been shown in the normal faecal flora in a population in south India. The dihydrofolate reductase (dhfr) genes mediating transferable resistance to trimethoprim have been identified.
Tait, S, Amyes, S G
core  

DHFR (dihydrofolate reductase) [PDF]

open access: yes, 2016
Dihydrofolate reductase (DHFR) is a member of the reductase enzyme family, which is ubiquitously expressed in all organisms. Levels of this enzyme peak at the G1/S cell cycle boundary. Autoregulation, through DHFR-RNA interactions, has also been reported.
Krajinovic, Maja   +2 more
core   +1 more source

Heterogeneity in the specific activity and methotrexate sensitivity of dihydrofolate reductase from blast cells of acute myelogenous leukemia patients.

open access: yes, 1985
Dihydrofolate reductase activity was found to be highly heterogeneous in terms of its specific activity and methotrexate sensitivity in the blast cells of patients with acute myelogenous leukemia.
J H Goldie   +4 more
core   +1 more source

Detection of Amino Acid Mutations in Dihydrofolate Reductase & Dihydro Pteroate Synthase Gene in Plasmodium Vivax Isolates [PDF]

open access: yesJLUMHS, 2020
OBJECTIVE: To assess the frequency and patterns of mutations and distribution of alleles in Plasmodium. Vivax Dihydrofolate Reductase (DHFR) & Dihydro Pteroate Synthase (DHPS) genes in Karachi.
Rizwana Yasmin   +4 more
doaj   +1 more source

Next‐Generation Glutamine Synthetase Expression Vector for Therapeutic Protein Manufacturing Using CHO Cells

open access: yesBiotechnology and Bioengineering, EarlyView.
ABSTRACT The glutamine synthetase expression system is widely used for therapeutic protein biomanufacturing in Chinese hamster ovary (CHO) cells. Here, we present the design of an enhanced glutamine synthetase vector for generating CHOK1SV GS‐KO stable pools that produce recombinant proteins at multigram‐per‐liter levels. We first developed a synthetic
Yusuf B. Johari   +11 more
wiley   +1 more source

A calibration curve for immobilized dihydrofolate reductase activity assay

open access: yesData in Brief, 2015
An assay was developed for measuring the active-site concentration, activity, and thereby the catalytic turnover rate (kcat) of an immobilized dihydrofolate reductase model system (Singh et al., (2015), Anal. Biochem).
Priyanka Singh   +3 more
doaj   +1 more source

Harnessing ferroptosis from multilayer defense networks to nanoplatforms for specific cancer therapy

open access: yesBMEMat, EarlyView.
Nanomaterials target metabolically‐regulated ferroptosis for cancer therapy. Iron‐based or alternative nanoplatforms integrate ferroptosis with chemotherapy, immunotherapy, or radiotherapy. They enable stimulus‐responsive therapies (photothermal, photodynamic, sonodynamic) activated by near‐infrared, light, or ultrasound, achieving potent synergistic ...
Xinyue Xu   +5 more
wiley   +1 more source

Supplementary from Dihydrofolate reductase amplification and sensitization to methotrexate of methotrexate-resistant colon cancer cells

open access: yes, 2009
Supplementary from Dihydrofolate reductase amplification and sensitization to methotrexate of methotrexate-resistant colon cancer ...
Cristina Morales (83591)   +6 more
core   +1 more source

Inherited metabolic epilepsies–established diseases, new approaches

open access: yesEpilepsia Open, EarlyView.
Abstract Inherited metabolic epilepsies (IMEs) represent the inherited metabolic disorders (IMDs) in which epilepsy is a prevailing component, often determining other neurodevelopmental outcomes associated with the disorder. The different metabolic pathways affected by individual IMEs are the basis of their rarity and heterogeneity.
Itay Tokatly Latzer, Phillip L. Pearl
wiley   +1 more source

Home - About - Disclaimer - Privacy